[Skip to Content]
[Skip to Content Landing]
May 18, 1907


JAMA. 1907;XLVIII(20):1680-1681. doi:10.1001/jama.1907.02520460036006

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The difficulties and disadvantages connected with the present nomenclature of the rapidly increasing number of synthetic chemicals introduced into medicine is forcibly presented in a recent issue of the British Medical Journal. Three phases of the difficulty present themselves: 1. The distinctive and systematic chemical terms are too meaningless to the ordinary physician and too long and cumbersome for common use. 2. The shorter names introduced by the manufacturers are arbitrary and, being protected by registration, are intended to prevent the use of the products of rival houses when the patents expire. 3. If a preparation shows any degree of popularity it is likely to be introduced by other firms under new names so that the multiplicity of names for the same article becomes confusing. Further, it is possible that a substance which has proved unsatisfactory may be again introduced under a new name and be considerably used before its

First Page Preview View Large
First page PDF preview
First page PDF preview